Report - Cancer Discovery - Targeting HER2 with Trastuzumab Deruxtecan: … · 2020. 3. 20. · HER2-positive metastatic gastric cancer (1–4). Dual blockade with trastuzumab and pertuzumab,

Please pass captcha verification before submit form